A Multi-center, Double-blind, Double-dummy, Randomized, Placebo- and Active-reference, Parallel Group, Phase 2, Dose-finding Study With ACT-132577 in Subjects With Essential Hypertension (Grade 1 and 2).
Phase: PHASE2
Conditions: Essential Hypertension
Sponsor: Idorsia Pharmaceuticals Ltd.

Protocol 
AC-080A201 
Multi-center, double-blind, double-dummy, randomized, placebo- and active-reference, 
parallel group, Phase 2 dose-finding study with ACT-132577 in subjects with essential 
hypertension (grade 1 and 2) 
ClinicalTrials.gov Identifier: NCT02603809 
This study was sponsored by Actelion Pharmaceuticals - study sponsorship was transferred to ldorsia 
Pharmaceuticals Ltd.